Pharmaceutical Biotechnology

Master of Science (MSc)

Pharmaceutical Biotechnology

Pharmaceutical biotechnology is a science of the future that deals with the development of innovative strategies for the rapid and efficient transfer of the latest medical and pharmacological findings into safe and highly effective pharmaceutical products. It deliberately operates at the interface between (bio)chemistry, medicine and biotechnology and thus combines many aspects of modern life sciences.

Current information: The Pharmaceutical Biotechnology (PBT) degree programme is being further developed in terms of content and structure and will be given a new name: Pharmaceutical and Molecular Biotechnology (PMB). Applications for the new PMB degree programme will be accepted starting in the 2026/2027 winter semester. Applications for PBT will no longer be accepted after this date. For more information, see Latest news.

More about the course

The cooperative master's programme "Pharmaceutical Biotechnology" at Ulm University and Biberach University of Applied Sciences teaches students how Medicine and pharmacological findings are translated into highly effective pharmaceutical products. In a cooperative degree programme at both locations, students learn about the interfaces between Chemistry, Biology, Medicine and Biotechnology. The focus is on bioprocess development and the production of therapeutic proteins as well as industrial processes. Graduates have a wide range of career opportunities in the biotechnological and pharmaceutical industries.

Academic Degree

Master of Science (MSc)

Type of Study
  • Full-time
Start of Study
  • will be transferred to a new programme starting in the 26/27 winter semester
University Place

40

Language of Instruction
  • German
Admission Requirements
  • No restriction
ECTS Credits

120

Standard Period of Study

4

Related Study Courses